Financial Highlights as at 30 June 2024
Share Price
$0.8840
Ordinary Shares in issue with voting rights
1,129.3m
Shares in Treasury
244.6m
NAV per Share
$1.0186
Discount to NAV per Share
13.2%
Net Assets
$1,150.3m
A Unique London-Listed Investment Company, Providing Access to Debt Capital for the Life Sciences Industry
LON · BPCR
BioPharma Credit PLC
$--
-- --%
Fetching...
BioPharma Credit PLC's primary objective is to generate predictable income for shareholders over the long term.